Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cone cell photopigments (opsins/photopsins) are light-sensitive G protein-coupled receptors located in the outer segment membranes of cone photoreceptor cells in the retina[2][3][4]. These molecules consist of an opsin protein—a transmembrane protein with seven transmembrane domains arranged in a barrel-like structure[1]—bound to the chromophore retinal (an oxidized derivative of vitamin A)[4]. Three distinct cone opsin variants exist, each with different peak wavelength sensitivities: L-opsin (red/long wavelength), M-opsin (green/medium wavelength), and S-opsin (blue/short wavelength)[4][7]. When photons strike the photopigment, they trigger photoisomerization of the retinal chromophore, causing a conformational change in the opsin that initiates the phototransduction cascade, ultimately generating electrical signals that enable color vision and daylight sight[3][4]. Unlike rod photopigments (rhodopsin), cone opsins reside on open disc membranes that remain continuous with the cell's plasma membrane, allowing rapid molecular exchange and supporting the high metabolic demands of daylight vision[3]. Mutations in cone opsin genes and dysregulation of cone opsin expression are associated with color blindness, enhanced S-cone syndrome, and other inherited retinal dystrophies, making cone opsins relevant targets for understanding and potentially treating retinal disease[3].
Cone opsins function as light-activated GPCRs. When photons are absorbed by the retinal chromophore bound within the opsin's transmembrane barrel structure[1], the opsin undergoes a conformational change from 11-*cis*-retinal to all-*trans*-retinal[3]. This activated opsin binds to the G-protein transducin, initiating a phototransduction cascade that ultimately modulates cGMP-gated ion channels and generates electrical signals[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cone opsin (also known as photopsin) (Varies by cone type (L-opsin, M-opsin, S-opsin for long, medium, and short wavelength cones, respectively)).